Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shambavi Richard

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Expert Review of Hematology|August 1, 2020
Immunomodulatory drug- and proteasome inhibitor-backbone regimens in the treatment of relapsed multiple myeloma: an evidence-based reviewLarysa Sanchez, Kevin Barley, Joshua Richter, et al.
Therapeutic Advances in Hematology|February 22, 2021
Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myelomaLarysa Sanchez, Joshua Richter, Hearn Jay Cho, et al.
Blood Cancer Discovery|October 18, 2021
Bispecific Antibodies in Multiple Myeloma: Present and FutureGuido Lancman, Dahniel L Sastow, Hearn J Cho, et al.
American Journal of Hematology|October 6, 2022
Trial designs and endpoints for immune therapies in multiple myelomaGuido Lancman, Erin Moshier, Hearn Jay Cho, et al.
Haematologica|July 2, 2026
Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myelomaTarek H Mouhieddine, Junia Vieira Dos Santos, Harshita Sehgal, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 15, 2021
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple MyelomaGuido Lancman, Katleen Lozada, Nida Athar, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 5, 2021
The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple MyelomaAnthony D Nehlsen, Kunal K Sindhu, Erin Moshier, et al.
Haematologica|April 23, 2026
Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumabGuido Lancman, Dahniel Sastow, Minira Aslanova, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forwardBo Wang, Oliver Van Oekelen, Tarek H Mouhieddine, et al.
Journal of Hematology & Oncology|July 16, 2020
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forwardBo Wang, Oliver Van Oekelen, Tarek H Mouhieddine, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Expert Review of Hematology|August 1, 2020
Immunomodulatory drug- and proteasome inhibitor-backbone regimens in the treatment of relapsed multiple myeloma: an evidence-based reviewLarysa Sanchez, Kevin Barley, Joshua Richter, et al.
Therapeutic Advances in Hematology|February 22, 2021
Subcutaneous daratumumab and hyaluronidase-fihj in newly diagnosed or relapsed/refractory multiple myelomaLarysa Sanchez, Joshua Richter, Hearn Jay Cho, et al.
Blood Cancer Discovery|October 18, 2021
Bispecific Antibodies in Multiple Myeloma: Present and FutureGuido Lancman, Dahniel L Sastow, Hearn J Cho, et al.
American Journal of Hematology|October 6, 2022
Trial designs and endpoints for immune therapies in multiple myelomaGuido Lancman, Erin Moshier, Hearn Jay Cho, et al.
Haematologica|July 2, 2026
Emapalumab and eltrombopag rescue for prolonged immune effector cell-associated hemophagocytic syndrome after CAR T-cell therapy in multiple myelomaTarek H Mouhieddine, Junia Vieira Dos Santos, Harshita Sehgal, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 15, 2021
Efficacy of Intravenous Immunoglobulin for Preventing Infections in Patients with Multiple MyelomaGuido Lancman, Katleen Lozada, Nida Athar, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 5, 2021
The Safety and Efficacy of Radiation Therapy with Concurrent Dexamethasone, Cyclophosphamide, Etoposide, and Cisplatin-Based Systemic Therapy for Multiple MyelomaAnthony D Nehlsen, Kunal K Sindhu, Erin Moshier, et al.
Haematologica|April 23, 2026
Effect of intravenous immunoglobulin on infections in multiple myeloma patients receiving daratumumabGuido Lancman, Dahniel Sastow, Minira Aslanova, et al.
Medrxiv : the Preprint Server for Health Sciences|June 25, 2020
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forwardBo Wang, Oliver Van Oekelen, Tarek H Mouhieddine, et al.
Journal of Hematology & Oncology|July 16, 2020
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forwardBo Wang, Oliver Van Oekelen, Tarek H Mouhieddine, et al.
Pageof 6